Ronco C - Search Results

1

Recent Advances in Age-Related Macular Degeneration Therapies.

Fabre M, Mateo L, Lamaa D, Baillif S, Pagès G, Demange L, Ronco C, Benhida R. Fabre M, et al. Among authors: ronco c. Molecules. 2022 Aug 10;27(16):5089. doi: 10.3390/molecules27165089. Molecules. 2022. PMID: 36014339 Free PMC article. Review.

2

Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges.

Millet A, Martin AR, Ronco C, Rocchi S, Benhida R. Millet A, et al. Among authors: ronco c. Med Res Rev. 2017 Jan;37(1):98-148. doi: 10.1002/med.21404. Epub 2016 Aug 29. Med Res Rev. 2017. PMID: 27569556 Review.

3

Discovery and Optimization of N-(4-(3-Aminophenyl)thiazol-2-yl)acetamide as a Novel Scaffold Active against Sensitive and Resistant Cancer Cells.

Millet A, Plaisant M, Ronco C, Cerezo M, Abbe P, Jaune E, Cavazza E, Rocchi S, Benhida R. Millet A, et al. Among authors: ronco c. J Med Chem. 2016 Sep 22;59(18):8276-92. doi: 10.1021/acs.jmedchem.6b00547. Epub 2016 Sep 12. J Med Chem. 2016. PMID: 27575313

4

Structure activity relationship and optimization of N-(3-(2-aminothiazol-4-yl)aryl)benzenesulfonamides as anti-cancer compounds against sensitive and resistant cells.

Ronco C, Millet A, Plaisant M, Abbe P, Hamouda-Tekaya N, Rocchi S, Benhida R. Ronco C, et al. Bioorg Med Chem Lett. 2017 May 15;27(10):2192-2196. doi: 10.1016/j.bmcl.2017.03.054. Epub 2017 Mar 23. Bioorg Med Chem Lett. 2017. PMID: 28372910

5

The GRP78/BiP inhibitor HA15 synergizes with mitotane action against adrenocortical carcinoma cells through convergent activation of ER stress pathways.

Ruggiero C, Doghman-Bouguerra M, Ronco C, Benhida R, Rocchi S, Lalli E. Ruggiero C, et al. Among authors: ronco c. Mol Cell Endocrinol. 2018 Oct 15;474:57-64. doi: 10.1016/j.mce.2018.02.010. Epub 2018 Feb 20. Mol Cell Endocrinol. 2018. PMID: 29474877

6

Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories.

Martin AR, Ronco C, Demange L, Benhida R. Martin AR, et al. Among authors: ronco c. Medchemcomm. 2016 Oct 19;8(1):21-52. doi: 10.1039/c6md00432f. eCollection 2017 Jan 1. Medchemcomm. 2016. PMID: 30108689 Free PMC article. Review.

7

ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells.

Ronco C, Martin AR, Demange L, Benhida R. Ronco C, et al. Medchemcomm. 2016 Nov 30;8(2):295-319. doi: 10.1039/c6md00439c. eCollection 2017 Feb 1. Medchemcomm. 2016. PMID: 30108746 Free PMC article. Review.

8

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.

Dufies M, Grytsai O, Ronco C, Camara O, Ambrosetti D, Hagege A, Parola J, Mateo L, Ayrault M, Giuliano S, Grépin R, Lagarde N, Montes M, Auberger P, Demange L, Benhida R, Pagès G. Dufies M, et al. Among authors: ronco c. Theranostics. 2019 Jul 9;9(18):5332-5346. doi: 10.7150/thno.34681. eCollection 2019. Theranostics. 2019. PMID: 31410218 Free PMC article.

9

Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent.

Brachet E, Dumond A, Liu WQ, Fabre M, Selkti M, Raynaud F, Hermine O, Benhida R, Belmont P, Garbay C, Lepelletier Y, Ronco C, Pagès G, Demange L. Brachet E, et al. Among authors: ronco c. Bioorg Med Chem Lett. 2019 Dec 15;29(24):126710. doi: 10.1016/j.bmcl.2019.126710. Epub 2019 Oct 16. Bioorg Med Chem Lett. 2019. PMID: 31699610

10

Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.

Baladi T, Hamouda-Tekaya N, Gonçalves LCP, Rocchi S, Ronco C, Benhida R. Baladi T, et al. Among authors: ronco c. ChemMedChem. 2020 Jul 3;15(13):1113-1117. doi: 10.1002/cmdc.202000218. Epub 2020 May 12. ChemMedChem. 2020. PMID: 32347004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,581 results

Search Page